The utilization of positron emission tomography in the evaluation of renal health and disease

Ogobuiro I, Tuma F. Physiology, renal. In: StatPearls. Treasure Island: StatPearls Publishing LLC; 2021. NBK538339 [bookaccession]

Gerich JE, Meyer C, Woerle HJ, Stumvoll M (2001) Renal gluconeogenesis: Its importance in human glucose homeostasis. Diabetes Care 24(2):382–391

Gerich JE (2010) Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabetic Med 27:136–142

Joven J, Vilella E (1993) Lipoprotein heterogeneity in end-stage renal disease. Kidney Int 43:410–418

Webster AC, Bardhan M (2017) Chronic kidney disease. Lancet 389(10075):1238–1252

Guder WG, Wagner S, Wirthensohn G (1986) Metabolic fuels along the nephron: pathways and intracellular mechanisms of interaction. Kidney Int 29:41–45

Hems R, Ross B (1980) The metabolic fate of lactate in renal cortical tubules. Biochem J 190:27–37

Song P, Onishi A, Koepsell H, Vallon V (2016) Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus. Expert Opin Ther Targets 20(9):1109–1125

Blaine J, Chonchol M, Levi M (2015) Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 10(7):1257–1272

Guertl B, Noehammer C, Hoefler G (2000) Metabolic cardiomyopathies. Int J Exp Pathol 81(6):349–372

Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ (2008) Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73(1):19–33

Klahr S, Levey AS, Beck GJ et al (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. N Engl J Med 330(13):877–884

Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–986

Slee AD (2012) Exploring metabolic dysfunction in chronic kidney disease. Nutr Metab (Lond) 9(1):1–16

Werner R, Xinyu C (2019) The next era of renal radionuclide imaging: Novel PET radiotracers. Eur J Nucl Med Mol Imaging 46(9):1773–1786

Juillard L, Janier MF, Fouque D et al (2000) Renal blood flow measurement by positron emission tomography using 15O-labeled water. Kidney Int 57(6):2511–2518

Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data generalizations. J Cereb Blood Flow Metab 5(4):584–590

Rebelos E, Immonen H, Bucci M et al (2019) Brain glucose uptake is associated with endogenous glucose production in obese patients before and after bariatric surgery and predicts metabolic outcome at follow-up. Diabetes Obes Metab 21(2):218–226

Oldgren J, Laurila S, Åkerblom A et al (2021) Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study. Diabetes Obes Metab 23:1505–1517

Immonen H, Hannukainen JC, Iozzo P et al (2014) Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. J Hepatol 60(2):377–383

Ng JM, Bertoldo A, Minhas DS et al (2014) Dynamic PET imaging reveals heterogeneity of skeletal muscle insulin resistance. J Clin Endocrinol Metab 99(1):E102–E106

Dadson P, Landini L, Helmio M et al (2016) Effect of bariatric surgery on adipose tissue glucose metabolism in different depots in patients with or without type 2 diabetes. Diabetes Care 39(2):292–299

Dadson P, Ferrannini E, Landini L et al (2017) Fatty acid uptake and blood flow in adipose tissue compartments of morbidly obese subjects with or without type 2 diabetes: effects of bariatric surgery. Am J Physiol Endocrinol Metab 313(2):E175–E182

Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1–9

Institute JB (2020) Critical appraisal tools for use in JBI systematic reviews checklist for prevalence studies. The University of Adelaide, Adelaide

Barrios L, Bergstrom K (2016) Radiolabeled sugars used for PET and SPECT imaging. Curr Radiopharm 9:180–186

Inaba T, Yamashita M, Kawase Y, Nakahashi H, Watanabe H (1989) Quantitative measurement of renal plasma flow by positron emission tomography with oxygen-15 water. Tohoku J Exp Med 159(4):283–289

Nitzschem EU, Choi Y, Killion D, Hoh CK, Hawkins RA, Schelbert R (1993) Quantification and parametric imaging of renal cortical blood flow in vivo based on patlak graphical analysis. Kidney Int 44(5):985–996

Middlekauff HR, Nitzsche EU, Hamilton MA et al (1995) Evidence for preserved cardiopulmonary baroreflex control of renal cortical blood flow in humans with advanced heart failure: a positron emission tomography study. Circulation 92:395–401

Middlekauff HR, Nitzsche EU, Nguyen AH, Hoh CK, Gibbs GG (1997) Modulation of renal cortical blood flow during static exercise in humans. Circ Res 80(1):62–68

Middlekauff HR, Nitzsche EU, Hoh CK et al (2000) Exaggerated renal vasoconstriction during exercise in heart failure patients. Circulation 101(7):784–789

Juillard L, Janier MF, Fouque D et al (2002) Dynamic renal blood flow measurement by positron emission tomography in patients with CRF. Am J Kidney Dis 40(5):947–954. https://doi.org/10.1053/ajkd.2002.36325

Kudomi N, Koivuviita N, Liukko KE et al (2009) Parametric renal blood flow imaging using [15O]H2O and PET. Eur J Nucl Med Mol Imaging 36(4):683–691

Damkjær M, Vafaee M, Braad PE, Petersen H, Høilund-Carlsen PF, Bie P (2012) Renal cortical and medullary blood flow during modest saline loading in humans. Acta physiol 205(4):472–483

Green MA, Hutchins GD (2011) Positron emission tomography (PET) assessment of renal perfusion. Semin Nephrol 31(3):291–299

Koivuviita N, Liukko K, Kudomim N et al (2012) The effect of revascularization of renal artery stenosis on renal perfusion in patients with atherosclerotic renovascular disease. Nephrol Dialysis Transp 27(10):3843–3848

Normand G, Lemoine S, Le Bars D et al (2019) PET [(11)C]acetate is also a perfusion tracer for kidney evaluation purposes. Nucl Med Biol 76–77:10–14

Rebelos E, Dadson P, Oikonen V et al (2019) Renal hemodynamics and fatty acid uptake: effects of obesity and weight loss. Am J Physiol Endocrinol Metab 317(5):E871–E878

Päivärinta J, Oikonen V, Räisänen-Sokolowski A et al (2019) Renal vascular resistance is increased in patients with kidney transplant. BMC Nephrol 20(1):437

Lacy J, Guerrero L, Christian B, Stone C (2010) Renal perfusion with 62cu-ETS in comparison with 15O-water PET. J Nucl Med 51(supplement 2):587–587

Tahari AK, Bravo PE, Rahmim A, Bengel FM (2014) Initial human experience with rubidium-82 renal PET/CT imaging. J Med Imaging Radiat Oncol 58:25–31

Keramida G, Gregg S, Peters AM (2020) Stimulation of the hepatic arterial buffer response using exogenous adenosine: hepatic rest/stress perfusion imaging. Eur Radiol 30(11):5852–5861

Guglielmo P, Ekström S, Strand R et al (2020) Validation of automated whole-body analysis of metabolic and morphological parameters from an integrated FDG-PET/MRI acquisition. Sci Rep 10(1):5331

Jadoul A, Lovinfosse P, Bouquegneau A et al (2020) Observer variability in the assessment of renal F-FDG uptake in kidney transplant recipients. Sci Rep 10(1):4617

Lovinfosse P, Weekers L, Bonvoisin C et al (2016) Fluorodeoxyglucose F(18) positron emission tomography coupled with computed tomography in suspected acute renal allograft rejection. Am J Transplant 16(1):310–316

Werner RA, Ordonez AA, Sanchez-Bautista J et al (2019) Novel functional renal PET imaging with 18F-FDS in human subjects. Clin Nucl Med 44(5):410–411

Derlin T, Gueler F, Bräsen JH et al (2017) Integrating MRI and chemokine receptor CXCR4-targeted PET for detection of leukocyte infiltration in complicated urinary tract infections after kidney transplantation. J Nucl Med 58(11):1831–1837

Geist B, Baltzer P, Fueger B, Hamboeck M, Hacker M, Staudenherz A (2018) Assessing the kidney function parameters glomerular filtration rate and effective renal plasma flow dynamic FDG-PET/MRI in healthy subjects. EJNMMI Res 8:37

Qiao H, Bai J, Chen Y, Tian J (2008) Modeling the excretion of FDG in human kidneys using dynamic PET. Comput Biol Med 38(11):1171–1176. https://doi.org/10.1016/j.compbiomed.2008.09.006

Rasul S, Geist BK, Brath H et al (2020) Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using 18F-FDG PET/MRI. BMJ Open Diabetes Res Care 8(1):e001135

Pajenda S, Rasul S, Hacker M, Wagner L, Geist BK (2020) Dynamic 2-deoxy-2[18F] fluoro-D-glucose PET/MRI in human renal allotransplant patients undergoing acute kidney injury. Sci Rep 10(1):8270

Minamimoto R, Takahashi N, Inoue T (2007) FDG-PET of patients with suspected renal failure: Standardized uptake values in normal tissues. Ann Nucl Med 21(4):217–222

Yamashita M, Inaba T, Kawase Y et al (1988) Quantitative measurement of renal function using ga-68-EDTA. Tohoku J Exp Med 155(2):207–208

Ruiz-Bedoya CA, Ordonez AA, Werner RA et al (2020) C-PABA as a PET radiotracer for functional renal imaging: preclinical and first-in-human study. J Nucl Med 61(11):1665–1671

Baldelomar EJ, Reichert DE, Shoghi KI et al (2021) Mapping nephron mass in vivo using positron emission tomography. Am J Physiol Renal Physiol 320(2):F183–F192 (Epub 2020 Dec 7)

Oliveira-Santos M, McMahon G, Castelo-Branco M et al (2020) Renal artery wall 18F-NaF activity and glomerular filtration rate: an exploratory analysis in a high cardiovascular risk population. Nucl Med Commun 41(2):126–132

Boss M, Buitinga M, Jansen TJP, Brom M, Visser EP, Gotthardt M (2020) PET-based human dosimetry of 68ga-NODAGA-exendin-4, a tracer for β-cell imaging. J Nucl Med 61(1):112–116

Naganawa M, Lim K, Nabulsi NB et al (2018) Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of FFP-DTBZ in healthy subjects and patients with type 1 diabetes. Mol Imaging Biol 20(5):835–845

Garg PK, Lokitz SJ, Truong L et al (2017) Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism. PLoS ONE 12(11):e0186340

Roivainen A, Någren K, Hirvonen J et al (2009) Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography. Eur J Nucl Med Mol Imaging 36(4):671–682

Kumar A, Muzik O, Chugani D, Chakraborty P, Chugani HT (2009) PET-derived biodistribution and dosimetry of the benzodiazepine receptor-binding radioligand (11)C-(R)-PK11195 in children and adults. J Nucl Med 51(1):139–144

McParland BJ, Miller MP, Spinks TJ, Kenny LM, Osman S, Cohen PS (2008) The biodistribution and radiation dosimetry of the arg-gly-asp peptide 18F-AH111585 in healthy volunteers. J Nucl Med 49(10):1664–1667

Ribeiro MJ, Ricard M, Lièvre MA, Bourgeois S, Emond P, Syrota A (2007) Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers. Nucl Med Biol 34(4):465–470

Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Någren KA, Rinne JO (2007) Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans. J Nucl Med 48(1):128–133

Nishii R, Higashi T, Kagawa S, Okuyama C, Saji H, Yamauchi H (2018) 18F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18F-FPYBF-2 PET imaging. Ann Nucl Med 32(4):256–263

Gormsen LC, Sundelin EI, Jensen JB et al (2016) In vivo imaging of human 11C-metformin in peripheral organs: dosimetry, biodistribution, and kinetic analyses. J Nucl Med 57(12):1920–1926

Roivainen A, Rinne J, Virta J et al (2004) Biodistribution and blood metabolism of 1–11C-methyl-4-piperidinyl n-butyrate inhumans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET. J Nucl Med 45(12):2032–2039

Jamar F, Barone R, Mathieu I et al (2003) 86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)—a phase 1 clinical study: Pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion. Eur J Nucl Med Mol Imaging 30(4):510–518

Ebenhan T, Sathekge MM, Lengana T et al (2018) Ga-NOTA-functionalized ubiquicidin: cytotoxicity, biodistribution, radiation dosimetry, and first-in human PET/CT imaging of infections. J Nucl Med 59(2):334–339

Champion C, Loirec C (2007) Positron follow-up in liquid water: II. Spatial and energetic study for the most important radioisotope used in PET. Phys Med Biol 52:6605–6625

Odudu A, Nery F, Harteveld AA et al (2018) Arterial spin labelling MRI to measure renal perfusion: a systematic review and statement paper. Nephrol Dial Transplant 33(suppl_2):ii15–ii21

Iskandrian AE, Dilsizian V, Garcia EV et al (2018) Myocardial perfusion imaging: lessons learned and work to be done-update. J Nucl Cardiol 25(1):39–52

Meury L, Noël J, Tejedor A, Sénécal J, Gougoux A, Vinay P (1994) Glucose metabolism in dog inner medullary collecting ducts. Ren Physiol Biochem 17(5):246–266

Tian Z, Liang M (2021) Renal metabolism and hypertension. Nat Commun 12(1):1–12

Nuutila P, Koivisto VA, Knuuti J et al (1992) Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89(6):1767–1774

Qiao H, Bai J, Chen Y, Tian J (2008) Modeling the excretion of FDG in human kidneys using dynamic PET. Comput Biol Med 38(11–12):1171–1176

Kaufman DP, Basit H, Knohl SJ. Physiology, glomerular filtration rate. In: StatPearls. Treasure Island: StatPearls Publishing LLC; 2021. NBK500032 [bookaccession].

Landau BR, Spring-Robinson CL, Muzic RF Jr et al (2007) 6-fluoro-6-deoxy-D-glucose as a tracer of glucose transport. Am J Physiol Endocrinol Metab 293(1):E237–E245

Scafoglio C, Hirayama BA, Kepe V et al (2015) Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A 112(30):E4111–E4119

Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612

Latva-Rasku A, Honka MJ, Kullberg J et al (2019) The SGLT2 inhibitor dapagliflozin reduces liver fat but does not affect tissue insulin sensitivity: a randomized, double-blind, placebo-controlled study with 8-week treatment in type 2 diabetes patients. Diabetes Care 42(5):931–937

Phoon RK (2012) Chronic kidney disease in the elderly—assessment and management. Aust Fam Physician 41(12):940–944

Kode V, Karsch H, Osman MM, Muzaffar R (2017) Impact of renal failure on F18-FDG PET/CT scans. Front Oncol 7:155

Bach-Gansmo T, Dybvik J, Adamsen T, Naum A (2012) Variation in urinary excretion of FDG, yet another uncertainty in quantitative PET. Acta Radiol Short Rep 1(8):1–3. https://doi.org/10.1258/arsr.2012.120038 (eCollection 2012)

Toriihara A, Kitazume Y, Nishida H, Kubota K, Nakadate M, Tateishi U (2015) Comparison of FDG-PET/CT images between chronic renal failure patients on hemodialysis and controls. Am J Nucl Med Mol Imaging 5(2):204–211

Hofman M, Binns D, Johnston V et al (2015) 68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: comparison to conventional 51Cr-EDTA. J Nucl Med 56(3):405–409

Goethals P, Volkaert A, Vandewielle C, Dierckx R, Lameire N (2000) 55Co-EDTA for renal imaging using positron emission tomography (PET): a feasibility study. Nucl Med Biol 27(1):77–81

Tek CK, Chennu KK, Amancharla YL, Manthri GR, Rapur R, Vishnubotla SK (2017) Utility of 18 F-FDG PET/CT scan to diagnose the etiology of fever of unknown origin in patients on dialysis. Hemodial Int 21(2):224–231

Lawal IO, Popoola GO, Lengana T, Ankrah AO, Ebenhan T, Sathekge M (2019) Diagnostic utility of F-FDG PET/CT in fever of unknown origin among patients with end-stage renal disease treated with renal replacement therapy. Hellenic J Nucl Med 22(1):70–75

Bleeker-Rovers CP, de Sévaux RG, van Hamersvelt HW, Corstens FH, Oyen WJ (2003) Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 41(6):E18-21

Fu Z, Li Z, Huang J et al (2016) High (18)F-FDG uptake in urinary calculi on PET/CT: An unrecognized non-malignant accumulation. Eur J Radiol 85(8):1395–1399

Hanssen O, Erpicum P, Lovinfosse P et al (2017) Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. in vivo imaging methods. Clin Kidney J 10(1):97–105

Reuter S, Schnockel U, Schroter R et al (2009) Non-invasive imaging of acute renal allograft rejection in rats using small animal F-FDG-PET. PLoS ONE 4:e5296

Aaltonen L, Koivuviita N, Seppänen M et al (2020) Correlation between (18)F-sodium fluoride positron emission tomography and bone histomorphometry in dialysis patients. Bone 134:11526